Ted Cohen
About
Ted Cohen is a scholar working on Infectious Diseases, Epidemiology and Surgery.
According to data from OpenAlex, Ted Cohen has authored 252 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Infectious Diseases, 164 papers in Epidemiology and 47 papers in Surgery. Recurrent topics in Ted Cohen's work include Tuberculosis Research and Epidemiology (174 papers), Pneumonia and Respiratory Infections (67 papers) and Mycobacterium research and diagnosis (59 papers). Ted Cohen is often cited by papers focused on Tuberculosis Research and Epidemiology (174 papers), Pneumonia and Respiratory Infections (67 papers) and Mycobacterium research and diagnosis (59 papers). Ted Cohen collaborates with scholars based in United States, United Kingdom and South Africa. Ted Cohen's co-authors include Marc Lipsitch, Megan Murray, Eric Tchetgen Tchetgen, Caroline Colijn, Megan Murray, Nicolas A. Menzies, Hsien-Ho Lin, Joshua A. Salomon, Helen E. Jenkins and Douglas Wilson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Ted Cohen
242 papers receiving 9.8k citations
Hit Papers
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ted Cohen | 5.8k | 4.8k | 1.7k | 1.6k | 986 | 252 | 10.0k | |
| Megan Murray | 7.7k 1.3× | 6.0k 1.2× | 2.6k 1.5× | 1.1k 0.7× | 1.0k 1.0× | 215 | 12.3k | |
| Yazdan Yazdanpanah | 6.6k 1.1× | 3.8k 0.8× | 1.0k 0.6× | 908 0.6× | 941 1.0× | 362 | 11.3k | |
| Pierre‐Yves Boëlle | 3.1k 0.5× | 4.4k 0.9× | 1.3k 0.8× | 4.1k 2.5× | 1.4k 1.4× | 302 | 12.7k | |
| John D. Clemens | 6.2k 1.1× | 4.4k 0.9× | 785 0.5× | 1.2k 0.7× | 2.1k 2.2× | 421 | 19.7k | |
| Vincent Chi‐Chung Cheng | 14.4k 2.5× | 5.2k 1.1× | 1.4k 0.8× | 2.1k 1.3× | 1.3k 1.3× | 369 | 23.1k | |
| Bin Cao | 15.7k 2.7× | 5.7k 1.2× | 1.2k 0.7× | 1.4k 0.9× | 847 0.9× | 308 | 26.7k | |
| Allen Cheng | 5.9k 1.0× | 8.7k 1.8× | 3.2k 1.9× | 671 0.4× | 1.3k 1.3× | 510 | 20.3k | |
| Mark A. Miller | 7.4k 1.3× | 8.7k 1.8× | 1.8k 1.0× | 1.7k 1.1× | 1.1k 1.1× | 254 | 17.1k | |
| Matthew H. Samore | 5.7k 1.0× | 5.5k 1.1× | 2.2k 1.3× | 909 0.6× | 1.5k 1.6× | 389 | 18.2k | |
| David N. Fisman | 3.7k 0.6× | 3.4k 0.7× | 495 0.3× | 3.0k 1.9× | 1.4k 1.4× | 241 | 11.8k |
Countries citing papers authored by Ted Cohen
Since
Specialization
Citations
This map shows the geographic impact of Ted Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted Cohen more than expected).
Fields of papers citing papers by Ted Cohen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ted Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted Cohen. The network helps show where Ted Cohen may publish in the future.
Co-authorship network of co-authors of Ted Cohen
This figure shows the co-authorship network connecting the top 25 collaborators of Ted Cohen. A scholar is included among the top collaborators of Ted Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted Cohen. Ted Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sweeney, Sedona, et al.. (2025). Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysis. The Lancet Global Health. 13(7). e1240–e1249.
2.
Haraguchi, Masahiko, Fayette Klaassen, Ted Cohen, Joshua A. Salomon, & Nicolas A. Menzies. (2025). Statistical Relationship Between Wastewater Data and Case Notifications for COVID-19 Surveillance in the United States From 2020 to 2023: Bayesian Hierarchical Modeling Approach. JMIR Public Health and Surveillance. 11. e68213–e68213.
3.
Cohen, Ted, Suzanne M. Marks, Andrew Hill, et al.. (2025). Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: A Bayesian Analysis. Clinical Infectious Diseases. 81(6). e659–e667.
4.
Sobol, Robert W., Shaheed Vally Omar, Tyler S. Brown, et al.. (2025). Transmission of bedaquiline-resistant Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. American Journal of Respiratory and Critical Care Medicine. 212(1). 138–147.
5.
Klaassen, Fayette, Melanie H. Chitwood, Masahiko Haraguchi, et al.. (2025). National- and State-level SARS-CoV-2 Immunity Trends From January 2020 to December 2023: a Mathematical Modeling Analysis. The Journal of Infectious Diseases.
6.
Horsburgh, C. Robert, et al.. (2025). Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants. PLoS Medicine. 22(5). e1004603–e1004603.
7.
Regan, Mathilda, Garrett R. Beeler Asay, Ted Cohen, et al.. (2024). Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003–19: an analysis of national surveillance data. The Lancet Public Health. 9(1). e47–e56.
8.
Klaassen, Fayette, Melanie H. Chitwood, Ted Cohen, et al.. (2022). Population Immunity to Pre-Omicron and Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Variants in US States and Counties Through 1 December 2021. Clinical Infectious Diseases. 76(3). e350–e359.
9.
Chitwood, Melanie H., Patrícia Bartholomay, Mauro Niskier Sanchez, et al.. (2022). A spatial-mechanistic model to estimate subnational tuberculosis burden with routinely collected data: An application in Brazilian municipalities. SHILAP Revista de lepidopterología. 2(9). e0000725–e0000725.
10.
Pitzer, Virginia E., Melanie H. Chitwood, Joshua Havumaki, et al.. (2021). The Impact of Changes in Diagnostic Testing Practices on Estimates of COVID-19 Transmission in the United States. American Journal of Epidemiology. 190(9). 1908–1917.
11.
Brown, Tyler S., Vegard Eldholm, Ola Brynildsrud, et al.. (2021). Evolution and emergence of multidrug-resistant Mycobacterium tuberculosis in Chisinau, Moldova. Microbial Genomics. 7(8).
12.
Yaesoubi, Reza, Joshua Havumaki, Melanie H. Chitwood, et al.. (2021). Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic. Medical Decision Making. 41(4). 386–392.
13.
Havumaki, Joshua, Ted Cohen, Joel C. Miller, et al.. (2021). Protective impacts of household-based tuberculosis contact tracing are robust across endemic incidence levels and community contact patterns. PLoS Computational Biology. 17(2). e1008713–e1008713.
14.
Walter, Katharine S., Caroline Colijn, Ted Cohen, et al.. (2020). Genomic variant-identification methods may alter Mycobacterium tuberculosis transmission inferences. Microbial Genomics. 6(8).
15.
Mabud, Tarub S., Albert I. Ko, Sanjay Basu, et al.. (2019). Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: An observational and modeling study from Brazil. PLoS Medicine. 16(1). e1002737–e1002737.
16.
Wilson, Douglas, et al.. (2018). Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements. Open Forum Infectious Diseases. 5(11). ofy253–ofy253.
17.
Menzies, Nicolas A., Ted Cohen, Andrew Hill, et al.. (2018). Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model. American Journal of Epidemiology. 187(9). 2011–2020.
18.
Kendall, Emily A., Sourya Shrestha, Ted Cohen, et al.. (2017). Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model. PLoS Medicine. 14(1). e1002202–e1002202.
19.
Chindelevitch, Leonid, Nicolas A. Menzies, Carel Pretorius, et al.. (2015). Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. Journal of The Royal Society Interface. 12(106). 20150146–20150146.
20.
Colijn, Caroline, Ted Cohen, Christophe Fraser, et al.. (2009). What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae ?. Journal of The Royal Society Interface. 7(47). 905–919.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Megan Murray Breakdown of academic impact, for papers by Yazdan Yazdanpanah Breakdown of academic impact, for papers by Pierre‐Yves Boëlle Breakdown of academic impact, for papers by John D. Clemens Breakdown of academic impact, for papers by Vincent Chi‐Chung Cheng Breakdown of academic impact, for papers by Bin Cao Breakdown of academic impact, for papers by Allen Cheng Breakdown of academic impact, for papers by Mark A. Miller Breakdown of academic impact, for papers by Matthew H. Samore Breakdown of academic impact, for papers by David N. Fisman